# A Phase II Study Looking at Moderate to Severe Osteoarthritis Knee Pain

> **NCT00394563** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 450 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** RN624 (PF-04383119)
- **DRUG:** RN624 (PF-04383119)
- **DRUG:** RN624 (PF-04383119)
- **DRUG:** RN624 (PF-04383119)
- **DRUG:** RN624 (PF-04383119)
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00394563
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 450 (ACTUAL)
- **Last updated:** 2009-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00394563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00394563, "A Phase II Study Looking at Moderate to Severe Osteoarthritis Knee Pain". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00394563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*